top of page
Image by Tron Le
Vietnam Pharmaceutical Registration

Your DAV Gateway

Regulatory . Certification . Licensing . Assurance

Navigate Vietnam's rapidly growing US$10 billion pharmaceutical market with expert local guidance. Our Vietnam-based team provides comprehensive DAV registration services to capture opportunities in this import-dominant market where 60% of pharmaceuticals are imported, valued at US$6 billion and projected to reach US$9.66 billion by 2026.

Why Vietnam

Exceptional Growth in Import-Dominant Pharmaceutical Market

Rapid Market Growth & Import Opportunities

As of 2020, the Vietnamese pharmaceutical market was valued at approximately US$10 billion, showcasing rapid growth and substantial potential for both local and imported drugs.

 

Import Market Dominance:

• Approximately 60% of pharmaceutical end products in Vietnam are imported

• Import market constitutes approximately US$6 billion in 2020

• Anticipated growth reaching US$9.66 billion by 2026

• Strong market credibility and desirability for imported pharmaceuticals

​

Market Structure & Opportunities

The Vietnamese pharmaceutical landscape presents unique opportunities

Regulatory Affairs Vietnam
Marketing Authorization Vietnam

Local vs. Import Balance:

• 60% imported pharmaceuticals demonstrating market openness

• 40% locally produced drugs complementing the market

• Import dominance elevating credibility and desirability of international pharmaceutical brands

• Strong consumer confidence in imported pharmaceutical products

​

Regulatory Framework Structure

The regulatory framework is overseen by the Drug Administration of Vietnam (DAV) under the Ministry of Health, ensuring comprehensive oversight of:

 

DAV Regulatory Responsibilities:

• Safety, efficacy, and quality control for all pharmaceutical products

• Marketing authorization and product registration processes

• Import licensing and compliance monitoring

• Post-market surveillance and pharmacovigilance

Regulatory Challenges & Modernization

However, navigating regulatory processes poses certain challenges:

 

Current Regulatory Environment:

• Bureaucratic hurdles requiring expert navigation

• Prolonged timelines within the DAV system

• Complex documentation and submission requirements

• Potential delays that may hinder timely product innovations

​

Market Structure & Opportunities

• Striking balance between affordability and drug safety remains a persistent challenge

• Ongoing modernization efforts to improve regulatory efficiency

• Government commitment to streamlining approval processes

• Technological integration initiatives to reduce bureaucratic barriers

Compliance Vietnam

Ready to Enter Vietnam's US$10 Billion Pharmaceutical Market?

Let's Navigate Your DAV Registration Success

Don't let regulatory complexity delay your entry into Vietnam's rapidly growing pharmaceutical market. Our Vietnam-based regulatory experts, with deep DAV knowledge and proven track record, are ready to accelerate your market access in this import-dominant market projected to reach US$9.66 billion by 2026.

 

Contact us today to discuss how our Vietnam expertise can unlock opportunities in Southeast Asia's fastest-growing pharmaceutical market.

bottom of page